Creative Biolabs-Immuno-oncology

Anti-CD133 (clone SDIE2E9Q3) SynExpress C-mCh-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR958)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD133 (clone SDIE2E9Q3). We employs the Lentivirus (CMV-mCherry-c-Jun-KpnI) vector components and the SynExpress system of the Exons Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD133
Clone
SDIE2E9Q3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
CMV
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.88
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.